MedTrace Logo

Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

NCT03427749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-04-10

Study results available
· View outcomes & findings →

Summary

Patients will be recruited from those referred to the local site's Diagnostic Imaging Department for SPECT myocardial perfusion imaging (MPI) ,who have an intermediate to high pre-test likelihood of disease (Diamond-Forrester criteria ≥ 30%) and are clinically indicated to have an MBF study.

Conditions

Interventions

DIAGNOSTIC_TEST

SPECT Imaging with 99mTc-Tetrofosmin Research Imaging

This is an observational study; patients will be managed according to the standard clinical care of the local site. Study end will be defined as completion of all SPECT imaging at rest and stress. Studies will be acquired at 6 initial sites with mixed prior experience at MBF imaging, to demonstrate feasibility of use in a clinical setting.

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • Ottawa Heart Institute Research Corporation

    lead OTHER

Principal Investigators

  • Terrence Ruddy, MD · Ottawa Heart Institute Research Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2022-10-01
Completion
2022-10-01

Countries

  • Belgium
  • Canada
  • Germany
  • Italy
  • Japan
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427749 on ClinicalTrials.gov